ID: ALA4789464

Max Phase: Preclinical

Molecular Formula: C26H50N4O12

Molecular Weight: 610.70

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  CCCCCCCC(=O)NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O

Standard InChI:  InChI=1S/C26H50N4O12/c1-2-3-4-5-6-7-15(32)30-9-13-18(34)20(36)21(37)26(39-13)42-24-12(28)8-11(27)23(22(24)38)41-25-19(35)16(29)17(33)14(10-31)40-25/h11-14,16-26,31,33-38H,2-10,27-29H2,1H3,(H,30,32)/t11-,12+,13-,14-,16+,17-,18-,19-,20+,21-,22-,23+,24-,25-,26-/m1/s1

Standard InChI Key:  QTOGNHCPLYDRND-NWZRKXCLSA-N

Associated Targets(Human)

Gap junction beta-2 protein 74 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Gap junction alpha-1 protein 92 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 610.70Molecular Weight (Monoisotopic): 610.3425AlogP: -4.77#Rotatable Bonds: 13
Polar Surface Area: 285.69Molecular Species: BASEHBA: 15HBD: 11
#RO5 Violations: 3HBA (Lipinski): 16HBD (Lipinski): 14#RO5 Violations (Lipinski): 3
CX Acidic pKa: 12.05CX Basic pKa: 9.34CX LogP: -4.32CX LogD: -8.06
Aromatic Rings: 0Heavy Atoms: 42QED Weighted: 0.09Np Likeness Score: 1.06

References

1. Subedi YP,Kjellgren A,Roberts P,Montgomery H,Thackeray N,Fiori MC,Altenberg GA,Chang CT.  (2020)  Amphiphilic aminoglycosides with increased selectivity for inhibition of connexin 43 (Cx43) hemichannels.,  203  [PMID:32679454] [10.1016/j.ejmech.2020.112602]

Source